The available literature suggests that dual ETA/ETB receptor antagonism is more effective than selective ETA receptor antagonism in order to fully prevent the deleterious actions of ET-1 in cardiovascular disease [7]. The gene discussed is EDN1; the disease is cardiovascular disorder.